Stock comparison

PFEvsRGC

Pfizer IncvsRegencell Bioscience Holdings Ltd. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

PFE

Pfizer Inc

$26.67

+3.17%

Pharmaceuticals$155.1BNYSE

RGC

Regencell Bioscience Holdings Ltd

$28.31

+70.54%

Pharmaceuticals$11.9BNASDAQ

60-day price, rebased to 100

PFE +3.13% · RGC -12.33%

Round-by-round

PFE 3·RGC 1· 2ties

Tie

Valuation upside

-18.10% vs — to DCF fair value

EdgeRGC

Balance-sheet strength

Altman Z 2.15 vs 32636.93

EdgePFE

Fundamental quality

Piotroski 6.00 vs 4.00 (of 9)

Tie

Growth + margins

Rule-of-40 12.90 vs —

EdgePFE

60-day momentum

+3.13% vs -12.33% price return

EdgePFE

Market-cap liquidity

$155.1B vs $11.9B

Verdict

Across6categories,PFEtakes the edge with3wins to1 (and 2 ties). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onPFEorRGC

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.